Sevelamer Carbonate

碳酸司维拉姆

Report date: 2024/03/20 11:41:54

Base Information

Drug NameSevelamer Carbonate
Drug Alias Name维拉姆sevelamerumt司维拉母RenvelaRenvela/Renagel +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperparathyroidismHyperphosphatemiaCardiovascular Diseases +[8] 
Global Approved IndicationsHyperphosphatemia
Approved Indications in ChinaHyperphosphatemia
Original Approved Country/TerritoryEU
Original Approved Date2000/01/28
Country/TerritoryUnited StatesSwedenPoland +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofiGenzyme Europe BvGenzyme Corp
Inactive CompaniesGenzyme Ireland LtdNational Institute Of Allergy And Infectious Diseases (Niaid)Sanofi (China) Investment Co Ltd +[5] 
Active IndicationsHyperphosphatemiaRenal Insufficiency, Chronic
Inactive IndicationsHyperparathyroidismCardiovascular DiseasesKidney Failure, Chronic +[6] 

Other Information

ATC CodeV03AE02
Related LinksWikipediaDrugBankKEGG